VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TSHA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
TSHATaysha Gene Therapies, Inc.
$6.50$1.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksTSHAQuarterly Financials

Taysha Gene Therapies, Inc. (TSHA) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Taysha Gene Therapies, Inc. (TSHA) quarterly income statement — complete revenue, gross profit & net income history

TSHA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue05.49M01.99M2.3M2.02M1.79M1.11M3.41M3.6M4.75M2.4M4.71M2.5M000000
Revenue Growth %-100%171.27%-100%78.6%-32.51%-43.9%-62.33%-53.57%-27.52%44.04%----------
Cost of Goods Sold0299K286K0000000331K703K631K1.68M000000
COGS % of Revenue-5.45%--------6.97%29.35%13.41%67.11%------
Gross Profit05.19M-286K1.99M2.3M2.02M1.79M1.11M3.41M3.6M4.42M1.69M4.08M823K000000
Gross Margin %-94.55%-100%100%100%100%100%100%100%93.03%70.65%86.59%32.89%------
Gross Profit Growth %-100%156.48%-116%78.6%-32.51%-43.9%-59.5%-34.28%-16.29%337.91%----------
Operating Expenses43.49M33.49M33.74M28.74M23.72M21.95M27.69M22.41M27.74M19.85M20.05M25.08M20.63M19.52M25.46M33.37M49.65M49.72M50.68M40.77M
OpEx % of Revenue-610.5%-1447.08%1030.54%1085.76%1548.43%2015.38%813.28%550.78%422.44%1047.01%438.46%780.3%------
Selling, General & Admin9.68M8.83M8.28M8.6M8.16M6.63M7.9M7.34M7.08M6.72M8.26M5.29M8.12M5.66M8.68M9.87M11.47M11.81M11.15M10.13M
SG&A % of Revenue-161.04%-432.93%354.39%327.84%441.95%659.89%207.68%186.43%174%220.67%172.55%226.3%------
Research & Development33.81M24.65M25.46M20.14M15.56M15.32M14.95M15.07M20.66M12.68M11.79M19.79M12.51M13.86M16.77M23.51M38.18M37.92M39.53M30.64M
R&D % of Revenue-449.46%-1014.15%676.15%757.91%835.91%1355.49%605.6%351.89%248.44%826.35%265.92%554%------
Other Operating Expenses0000001000K00449K0000000000
Operating Income-43.49M-28.3M-34.02M-26.75M-21.42M-19.93M-25.9M-21.3M-24.33M-16.25M-15.63M-23.38M-16.56M-18.7M-25.46M-33.37M-49.65M-49.72M-50.68M-40.77M
Operating Margin %--515.95%--1347.08%-930.54%-985.76%-1448.43%-1915.38%-713.28%-450.78%-329.41%-976.37%-351.87%-747.4%------
Operating Income Growth %-103.01%-41.98%-31.38%-25.61%11.96%-22.69%-65.65%8.92%-46.93%13.12%38.59%29.93%66.65%62.39%49.77%18.15%-54.72%-170.72%-236.95%-916.76%
EBITDA-43.49M-28M-33.74M-26.48M-21.14M-19.63M-25.6M-20.98M-24M-15.88M-15.3M-22.68M-15.93M-17.02M-25.18M-33.1M-49.39M-49.52M-50.52M-40.69M
EBITDA Margin %--510.5%--1333.13%-918.24%-970.72%-1431.99%-1886.42%-703.75%-440.62%-322.44%-947.01%-338.46%-680.3%------
EBITDA Growth %-105.72%-42.66%-31.77%-26.21%11.94%-23.6%-67.31%7.51%-50.71%6.7%39.23%31.48%67.75%65.62%50.15%18.65%-54.07%-169.67%-235.92%-91.74%
D&A (Non-Cash Add-back)0299K286K277K283K304K294K322K325K366K331K703K631K1.68M277K273K260K209K166K85K
EBIT0-28.3M-32.72M-26.86M-21.51M-18.76M-25.5M-20.9M-24.03M48.45M-115.62M-23.16M-16.25M-54.93M-25.45M-33.35M-49.65M-49.7M-50.64M-40.73M
Net Interest Income02.86M3.15M1.84M1.31M1.68M2.08M1.41M1.66M1.21M-362K-1.22M-1.05M-597K-1.07M-716K-658K-662K-506K-154K
Interest Income2.59M2.87M3.17M1.86M1.33M1.7M2.11M1.44M1.69M1.92M1.11M223K319K199K9K27K14K29K37K40K
Interest Expense-9K12K15K17K19K22K24K27K29K713K1.47M1.44M1.37M796K1.08M743K672K691K543K194K
Other Income/Expense1.08M449K1.29M-129K-108K1.15M374K371K269K63.99M-101.45M-1.21M-1.06M-37.02M-1.07M-719K-666K-662K-506K-154K
Pretax Income-42.41M-27.85M-32.73M-26.88M-21.53M-18.79M-25.52M-20.93M-24.06M47.74M-117.09M-24.6M-17.62M-55.72M-26.53M-34.09M-50.32M-50.39M-51.19M-40.93M
Pretax Margin %--507.77%--1353.58%-935.23%-929.03%-1427.52%-1882.01%-705.39%1324.67%-2467.07%-1027.06%-374.46%-2227.14%------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-42.41M-27.85M-32.73M-26.88M-21.53M-18.79M-25.52M-20.93M-24.06M47.74M-117.09M-24.6M-17.62M-55.72M-26.53M-34.09M-50.32M-50.39M-51.19M-40.93M
Net Margin %--507.77%--1353.58%-935.23%-929.03%-1427.52%-1882.01%-705.39%1324.67%-2467.07%-1027.06%-374.46%-2227.14%------
Net Income Growth %-96.99%-48.26%-28.24%-28.45%10.52%-139.35%78.2%14.92%-36.54%185.68%-341.39%27.85%64.98%-10.59%48.18%16.7%-57.12%-175.06%-240.29%-92.87%
Net Income (Continuing)-42.41M-27.85M-32.73M-26.88M-21.53M-18.79M-25.52M-20.93M-24.06M47.74M-117.09M-24.6M-17.62M-55.72M-26.53M-34.09M-50.32M-50.39M-51.19M-40.93M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.12-0.08-0.09-0.09-0.08-0.09-0.10-0.09-0.100.26-0.93-0.38-0.28-0.99-0.65-0.85-1.32-1.32-1.35-1.09
EPS Growth %-50.19%12.76%2.83%-0.33%20.1%-135.9%89.77%76.52%64.11%125.85%-43.75%54.92%78.86%25.26%51.89%22.23%-52.26%-172.54%-5.06%-79.02%
EPS (Basic)-0.12-0.08-0.09-0.09-0.08-0.09-0.10-0.09-0.100.26-0.93-0.38-0.28-0.99-0.65-0.85-1.32-1.32-1.35-1.09
Diluted Shares Outstanding366.63M319.71M353.31M297.99M269.31M204.94M267.82M232.82M231.25M186.96M125.7M64.24M63.26M56.39M40.94M40.14M38.17M38.11M38M37.48M
Basic Shares Outstanding366.63M319.71M353.31M297.99M269.31M204.94M267.82M232.82M231.25M186.96M125.7M64.24M63.26M56.39M40.94M40.14M38.17M38.11M38M37.48M
Dividend Payout Ratio--------------------